Lipids are a complex and diverse group of molecules with crucial roles in many
physiological processes, as well as in the onset, progression, and maintenance of cancers …

The bioactive sphingolipid metabolites ceramide and sphingosine-1-phosphate (S1P) are a
recent addition to the lipids accumulated in obesity and have emerged as important …

Fatty liver diseases can result from common metabolic diseases, as well as from xenobiotic
exposure and excessive alcohol use, all of which have been shown to exert toxic effects on …

While non-alcoholic fatty liver disease (NAFLD) is a prevalent and frequent cause of liver-
related morbidity and mortality, it is also strongly associated with cardiovascular disease …

Background and objectives Non-alcoholic fatty liver disease (NAFLD) develops due to
impaired hepatic lipid fluxes and is a risk factor for chronic liver disease and atherosclerosis …

The objective of this review is to provide a comprehensive summary of the latest
methodological advancements and emerging patterns in utilizing lipidomics in clinical …

Pediatric obesity is a progressive, chronic disease that can lead to serious cardiometabolic
complications. Here we investigated the peripheral lipidome in 958 children and …

Background Non-alcoholic fatty liver disease (NAFLD) is affecting more people globally.
Indeed, NAFLD is a spectrum of metabolic dysfunctions that can progress to hepatocellular …

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects one-third of the
global population. Understanding the metabolic pathways involved can provide insights into …

Lipid droplets (LDs) are a kind of subcellular organelle, and LDs' polarity is closely
associated with the initiation and development of non-alcoholic fatty liver disease (NAFLD) …